SCHEMBL246937

SCHEMBL246937

O=C(OC(=O)c1ccc(Br)cc1)c1ccc(Br)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.59
CES1 P23141 1/20 0.59
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
PTPRF P10586 1/20 0.52
PTPN2 P17706 1/20 0.52
PTPN1 P18031 1/20 0.52
RAB9A P51151 5/20 0.50
NPC1 O15118 4/20 0.50
KMT2A Q03164 3/20 0.50
GSK3B P49841 2/20 0.50
HPGD P15428 1/20 0.50
CYP2C9 P11712 1/20 0.50
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 4/20 0.48
MEN1 O00255 1/20 0.48
MAPK1 P28482 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246938 0.91 NPC1 (0.62) CES2CES1CA1CA2PTPRF
SCHEMBL11157577 0.87 ALOX15 (0.52) CES2CES1CA1CA2PTPRF
SCHEMBL29000045 0.86 CES2 (0.50) CES2CES1CA1CA2PTPRF
SCHEMBL27614677 0.84 CES2 (0.48) CES2CES1CA1CA2PTPRF
SCHEMBL3790497 0.84 CES2 (0.59) CES2CES1CA1CA2PTPRF
SCHEMBL20548926 0.83 CES2 (0.46) CES2CES1CA1CA2PTPRF
SCHEMBL28644091 0.83 HTT (0.49) CES2CES1CA1CA2PTPRF
SCHEMBL8674798 0.82 KMT2A (0.65) CES2CES1CA1CA2PTPN2
SCHEMBL22775249 0.82 CES2 (0.56) CES2CES1CA1CA2PTPRF
SCHEMBL27861351 0.82 CES2 (0.56) CES2CES1CA1CA2PTPRF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114995060-B Negative photosensitive resin composition capable of being cured at low temperature and preparation method and application thereof 明士(北京)新材料开发有限公司 2022-11-01 CN claimed
CN-110698659-B Phthalic anhydride polyester polyol and preparation method thereof 万华化学集团股份有限公司 2022-04-22 CN claimed
CN-114230792-A Positive photosensitive polyimide resin, resin composition, and preparation method and application thereof 明士(北京)新材料开发有限公司 2022-03-25 CN claimed
CN-111635526-B Polyether imide polymer containing carboxyl side group and preparation method and application thereof 吉林大学 2021-03-23 CN claimed
CN-111635526-A Polyether imide polymer containing carboxyl side group and preparation method and application thereof 吉林大学 2020-09-08 CN claimed
CN-110951076-A Hyperbranched polyetherimide and preparation and application thereof 北京化工大学 2020-04-03 CN claimed
CN-110698659-A Phthalic anhydride polyester polyol and preparation method thereof 万华化学集团股份有限公司 2020-01-17 CN claimed
US-20180273819-A1 THERMAL ENERGY STORAGE PHASE AND TEMPERATURE STABILIZATION CHANGE MATERIALS COMPRISING TRIAMINES AND METHODS FOR MAKING AND USING THEM ENTROPY SOLUTIONS LLC (US) 2018-09-27 US claimed
WO-2016179028-A1 THERMAL ENERGY STORAGE PHASE AND TEMPERATURE STABILIZATION CHANGE MATERIALS AND METHODS FOR MAKING AND USING THEM ENTROPY SOLUTIONS, LLC. (US) 2016-11-10 WO claimed
US-7247740-B2 Reacting perfluoroalkanesulfonic acid directly with dialkyl carbonate to give alkyl perfluoroalkanesulfonate optionally in the presence of a water or alcohol consuming reagent, and preparing an alkyl perfluoroalkanesulfonate with an alkylamine or alkylphosphine to prepare perfluoroalkanesulfonic acid MERCK PATENT GMBH (DE) 2007-07-24 US claimed
EP-1472217-B1 METHOD FOR PRODUCING PERFLUOROALKANE SULFONIC ACID ESTERS AND THE SALTS THEREOF MERCK PATENT GMBH (DE) 2007-01-24 EP claimed
US-20050085655-A1 Reacting perfluoroalkanesulfonic acid directly with dialkyl carbonate to give alkyl perfluoroalkanesulfonate optionally in the presence of a water or alcohol consuming reagent, and preparing an alkyl perfluoroalkanesulfonate with an alkylamine or alkylphosphine to prepare perfluoroalkanesulfonic acid MERCK PATENT GMBH (DE) 2005-04-21 US claimed
US-12215074-B2 Process for the production of peroxyesters NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2025-02-04 US disclosed
US-12209065-B2 Process for the production of diacyl peroxides NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2025-01-28 US disclosed
WO-2025015175-A2 HEATING, VENTILATION, AND AIR CONDITIONING (HVAC) SYSTEMS AND METHODS FOR USING SAME STASIS ENERGY GROUP, LLC (US) 2025-01-16 WO disclosed
US-11976034-B2 Process for the production of diacyl peroxides NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2024-05-07 US disclosed
US-3933895-A PROSTAGLANDINS, ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING THE UPJOHN COMPANY (US) 1976-01-20 US disclosed
US-3933896-A ANTICOAGULANTS, ASTHMA, LABOR INDUCERS, CERVICAL DILATION THE UPJOHN COMPANY (US) 1976-01-20 US disclosed
US-3933900-A ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING THE UPJOHN COMPANY (US) 1976-01-20 US disclosed
US-3933899-A ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING THE UPJOHN COMPANY (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085655-A1 Reacting perfluoroalkanesulfonic acid directly with dialkyl carbonate to give alkyl perfluoroalkanesulfonate optionally in the presence of a water or alcohol consuming reagent, and preparing an alkyl perfluoroalkanesulfonate with an alkylamine or alkylphosphine to prepare perfluoroalkanesulfonic acid PFKFB2, PFKFB3, PHOSPHO1 CES2 167/4885CES1 504/4885CA1 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.